SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-20-005732
Filing Date
2020-04-02
Accepted
2020-04-02 20:10:31
Documents
1
Period of Report
2020-03-23

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 2904
  Complete submission text file 0001493152-20-005732.txt   4328
Mailing Address 15 CUSHING IRVINE CA 92618
Business Address 15 CUSHING IRVINE CA 92618 949-409-7600
OncoCyte Corp (Issuer) CIK: 0001642380 (see all company filings)

IRS No.: 271041563 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 15 CUSHING IRVINE CA 92618
Business Address
Ross Douglas T. (Reporting) CIK: 0001808413 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37648 | Film No.: 20771276